Browsing by Author Shi, YM

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 6 of 6
TitleAuthor(s)Issue DateViews
 
Comparison of effectiveness of sodium glucose co-transporter-2 inhibitors (sglt2i) and glucagon-like peptide-1 receptor agonists (glp-1a) on cardiovascular disease, edd-stage renal disease and all-cause mortality for overweight/obese patients with type 2 diabetes mellitus
Proceeding/Conference:The 23rd Annual Scientific Meeting of the Institute of Cardiovascular Science and Medicine Cum the 10th Anniversary Scientific Symposium of the Department of Pharmacology and Pharmacy, The University of Hong Kong
Tang, HMWong, CKHShi, YMLam, CLK
2019
30
 
Convolution neural network in detecting lung diseases in frontal chest radiographs - A validation study in local Chinese population
Proceeding/Conference:Annual Scientific Meeting of Hong Kong College of Radiologists
Du, RShi, YMVardhanabhuti, V
2018
49
 
Oriented lateral growth of two-dimensional materials on c-plane sapphire
Journal:Nature Nanotechnology
Fu, JHMin, JCChang, CKTseng, CCWang, QXSugisaki, HLi, CYChang, YMAlnami, ISyong, WRLin, CFang, FEZhao, LLo, THLai, CSChiu, WSJian, ZSChang, WHLu, YJShih, KMLi, LJWan, YShi, YMTung, V
20-Jul-2023
 
Treatment intensification with Dipeptidylpeptidase-4 inhibitor, insulin, or Thiazolidinediones and risks of cardiovascular diseases and all-cause mortality in patients on metformin-sulfonylurea dual therapy
Proceeding/Conference:14th International Symposium on Healthy Aging, 2019
Shi, YMWong, CKHMan, KCKChan, EWHo, CWTse, TYEWong, ICKLam, CLK
2019
 
Triple Therapy with Dpp4 Inhibitor, Insulin, or Thiazolidinediones and Risks of Cardiovascular Diseases and All-Cause Mortality in Patients with Failed Metformin-SU Therapy
Proceeding/Conference:Journal of Hypertension
Wong, CKHShi, YMHo, CWTse, TYELam, CLK
2019
35
 
Weight loss, cardiovascular diseases and all-cause mortality of overweight/obese patients with type 2 diabetes mellitus initiating sodium glucose co-transporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1A)
Proceeding/Conference:International Congress on Obesity and Metabolic Syndrome & Asia-Oceania Conference on Obesity (ICOMES & AOCO), 2019
Tang, HMWong, CKHShi, YMLam, CLK
2019
38
Showing results 1 to 6 of 6